Placebo to Upadacitinib
M13-545
Phase 3 small_molecule completed
Quick answer
Placebo to Upadacitinib for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed